{
    "nct_id": "NCT06539468",
    "official_title": "Investigating Active Surveillance for Management of Low-Risk Basal Cell Carcinoma in the Elderly",
    "inclusion_criteria": "* Subject of any gender aged â‰¥ 65 years at the time of enrollment\n* Patient at University of Michigan Department of Dermatology (UMichDD)\n* Willing and able to provide informed consent\n* Willing and able to comply with the protocol requirements\n* Histopathologic diagnosis of one or more LR-BCC(s) within 2 months of enrollment. LR-BCC is defined here as biopsy proven primary (not recurrent) BCC of any morphologic subtype; < 2cm in size; with or without marginal involvement on histopathology; and located on the trunk or extremities excluding pretibial surface, hands, feet, nail units, and ankles (corresponding to area L in the Mohs Appropriate Use Criteria, representing the lowest risk areas)\nHealthy volunteers allowed\nMust have minimum age of 65 Years",
    "exclusion_criteria": "* Individuals who are immunocompromised per judgement of investigator (examples include but are not limited to patients on immunosuppressive medications such as prednisone > 10 mg daily, uncontrolled HIV, and organ transplant recipients on immunosuppressive therapy)\n* Individuals who expect to relocate and will be unable to return to UMichDD for clinical follow-up visit(s)\n* Individuals with a genetic syndrome predisposing to development of basal cell carcinoma",
    "miscellaneous_criteria": ""
}